CLINICAL CHARACTERISTICS OF RHEUMATOID ARTHRITIS PATIENTS TO BE INTENSIFIED INFLIXIMAB THERAPY

被引：0

作者：

Oguma, A. ^{[1
]}

Irino, K. ^{[1
]}

Sawabe, T. ^{[1
]}

机构：

[1] Hiroshima Red Cross & Atom Bomb Survivors Hosp, Rheumatol, Hiroshima, Japan

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2014年 / 73卷

关键词：

LEVEL;

D O I：

10.1136/annrheumdis-2014-eular.2546

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

AB0420

引用

页码：946 / 946

页数：1

共 3 条

[1] Impact of trough serum level on radiographic and clinical response to infliximab plus methotrexate in patients with rheumatoid arthritis: results from the RISING study [J].

Takeuchi, Tsutomu ;

Miyasaka, Nobuyuki ;

Inoue, Kazuhiko ;

Abe, Tohru ;

Koike, Takao .

MODERN RHEUMATOLOGY, 2009, 19 (05) :478-487

[2] Inhibition of plasma IL-6 in addition to maintenance of an efficacious trough level of infliximab associated with clinical remission in patients with rheumatoid arthritis: analysis of the RISING Study [J].

Takeuchi, Tsutomu ;

Miyasaka, Nobuyuki ;

Tatsuki, Yoshihiko ;

Yano, Toshiro ;

Yoshinari, Toru ;

Abe, Tohru ;

Koike, Takao .

ANNALS OF THE RHEUMATIC DISEASES, 2012, 71 (09) :1583-1585

[3] Baseline tumour necrosis factor alpha levels predict the necessity for dose escalation of infliximab therapy in patients with rheumatoid arthritis [J].

Takeuchi, Tsutomu ;

Miyasaka, Nobuyuki ;

Tatsuki, Yoshihiko ;

Yano, Toshiro ;

Yoshinari, Toru ;

Abe, Tohru ;

Koike, Takao .

ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 (07) :1208-1215

← 1 →